Abstract
Of the two well-known rodent models of human type 1 diabetes (the non-obese diabetic mouse and the BioBreeding rat) the mouse has become the model of choice. Here the authors re-examine the value of this mouse model as a tool for understanding human diabetes and for testing potential therapies, reviewing both strengths and weaknesses.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Contrast-enhanced ultrasound measurement of pancreatic blood flow dynamics predicts type 1 diabetes progression in preclinical models
Nature Communications Open Access 01 May 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout

References
Leiter, E.H. & Atkinson, M.A. NOD mice and related strains: Research applications in diabetes, AIDS, cancer and other diseases in Medical Intelligence Unit (R.G. Landes, Austin, 1998 ).
Delovitch, T.L. & Singh, B. The nonobese diabetic mouse as a model of autoimmune diabetes - immune dysregulation gets the NOD. Immunity 7, 727–738 (1997).
Rabinovich, A. An update of cytokines in the pathogenesis of insulin dependent diabetes mellitus . Diabetes Metab. Rev. 14, 129– 151 (1998).
Takahashi, K., Honeyman, M.C. & Harrison, L.C. Impaired yield, phenotype, and function of monocyte-derived dendritic cells in humans at risk for insulin dependent diabetes. J. Immunol. 161, 2629–2635 (1998).
Ellerman, K.E., Richards, C.A., Guberski, D.L., Shek, W.R. & Like, A.A. Kilham rat virus triggers T-cell-dependent autoimmune diabetes in multiple strains of rats. Diabetes 45, 557–562 (1996).
Komeda, K. et al. Establishment of 2 substrains, diabetes-prone and nondiabetic, from Long-Evans Tokushima-Lean (LETL) rats. J. Endocrinol. 45, 737–744 (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Atkinson, M., Leiter, E. The NOD mouse model of type 1 diabetes: As good as it gets?. Nat Med 5, 601–604 (1999). https://doi.org/10.1038/9442
Issue date:
DOI: https://doi.org/10.1038/9442
This article is cited by
-
Lentiviral gene therapy vectors encoding VIP suppressed diabetes-related inflammation and augmented pancreatic beta-cell proliferation
Gene Therapy (2021)
-
Modelling diabetic nephropathy in mice
Nature Reviews Nephrology (2018)
-
Contrast-enhanced ultrasound measurement of pancreatic blood flow dynamics predicts type 1 diabetes progression in preclinical models
Nature Communications (2018)
-
Human amylin induces CD4+Foxp3+ regulatory T cells in the protection from autoimmune diabetes
Immunologic Research (2018)
-
ERK1 is dispensable for mouse pancreatic beta cell function but is necessary for glucose-induced full activation of MSK1 and CREB
Diabetologia (2017)